ISSN 2639-9431
Vol. 8, Issue 2, 2025April 30, 2025 EDT
Elevated Nesfatin-1 and Altered Reproductive Hormones in Polycystic Ovary Syndrome: A Comparative Case-Control Study.
Elevated Nesfatin-1 and Altered Reproductive Hormones in Polycystic Ovary Syndrome: A Comparative Case-Control Study.
Articles in Vol. 8, Issue 2, 2025
Vol. 8, Issue 2, 2025
- Diagnosis of Alzheimer’s Disease, Parkinson’s Disease, Frontotemporal Dementia, and Paranoid Schizophrenia via Complex Network Analysis of EEG DataMiguel Angel Vargas Cruz
- Localized delivery of gel-embedded siRNA nanoparticles for pancreatic cancer treatment: Formulation, biodistribution and bioactivity in miceMajd AgbariaDoaa Jbara-AgbariaGershon Golomb
- Catalytic Nanomedicine: Antioxidant Action and Clinical Benefits Using Cerium Oxide NanoparticlesSofia Fernandes Coriolano AraujoRosana Anita Silva FonsecaAntonio Souza Araujo
- Precision Medicine in Africa: Current State and Strategies for developmentPatrick AshinzeWinner UnwabaBoluwatife AdeyemoJonathan AdeolaEniola AkandeOluwadamilare OlatunbosunToluwanimi OlatunbosunVictor Mayowa AdeleyeMichael OlaniteFrancis Ngirigwa
- Elevated Nesfatin-1 and Altered Reproductive Hormones in Polycystic Ovary Syndrome: A Comparative Case-Control Study.Zainab Ghazi MohammedHassan Ali Farman
- Development of a Predictive Model for Hepatitis B Virus (HBV) Status Using Gender and Serum BiomarkersStanley Obinna EzeadichieJoy E. IkekpeazuAmechi Uchenna KatchyMima WarisoChioma Cordelia UgwuOsah Martins Onwuka
Ghazi Mohammed, Zainab, and Hassan Ali Farman. 2025. “Elevated Nesfatin-1 and Altered Reproductive Hormones in Polycystic Ovary Syndrome: A Comparative Case-Control Study.” Precision Nanomedicine 8 (2): 1501–10. https://doi.org/10.33218/001c.137511.